Influence
July 7, 2021

Algorithm developed by Regenstrief/Merck collaboration hailed as promising research tool

A natural language processing (NLP) algorithm to identify patients with chronic cough, created and validated by Regenstrief Institute, Indiana University and Merck & Co. research scientists, is being recognized for its ingenuity and its potential.

The paper describing the algorithm’s development, Identifying and Characterizing a Chronic Cough Cohort Through Electronic Health Records, was published in the June 2021 edition of Chest Journal, along with an editorial written by Akio Niimi, M.D., PhD.

In the editorial, Dr. Niimi discussed the promise of the algorithm to improve chronic cough research. The condition is challenging to identify through electronic health records because it does not have an International Classification of Disease (ICD) code, therefore most indicators of the condition exist in unstructured data within the EHR. Cough is the most common complaint that leads patients to seek medical attention. Up to 40 percent of patients referred to specialist clinics do not learn the cause of their chronic cough, so this condition is an important research target.

In the study, led by Regenstrief research scientist and IU School of Medicine professor Michael Weiner, M.D., MPH, the algorithm improved detection of chronic cough patients nearly seven-fold and created the largest chronic cough cohort ever recorded.

Dr. Niimi states that chronic cough characterization from the EHR by NLP shows great potential as a research tool, enabling large cohort studies that were not possible before.

Funding for this research came from Merck & Co., Inc. This is part of a partnership between Regenstrief Institute and Merck to collaborate on projects using clinical data to inform delivery of healthcare.

Related News

Paul Musey, MD, MSC

Peer-supported online therapy improves anxiety after emergency visits for low-risk chest pain

Randomized trial finds peer-supported online therapy improved anxiety after discharge for low-risk chest pain, with the largest difference among

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists, fellows and affiliates shared work on artificial intelligence, health information exchange and public health informatics

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney